ESC 365 - THEMIS-PCI: Ticagrelor in Patients with Diabetes and Stable Coronary Artery Disease with a History of Prior Percutaneous Coronary Intervention

ESC Premium Access

THEMIS-PCI: Ticagrelor in Patients with Diabetes and Stable Coronary Artery Disease with a History of Prior Percutaneous Coronary Intervention

Session: Hot Line Session 1

Topic: Percutaneous Coronary Intervention (PCI) and Surgery

Speaker: Professor P. Steg (Paris, FR)

Event: ESC Congress 2019

Congress Presentation

About the speaker

Professor Philippe Gabriel Steg

Hopital Bichat, Paris (France)

47 presentations

8 followers

11 more presentations in this session

THEMIS - Main Results of the Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study

Speaker: Professor D. Bhatt (New York City, US)

Discussant review - THEMIS/THEMIS-PCI

Speaker: Professor C. Baigent (Oxford, GB)

Questions from the audience and discussion

PARAGON-HF - Angiotensin Receptor Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

Speaker: Professor S. Solomon (Boston, US)

Discussant review - PARAGON-HF.

Speaker: Doctor S. Connolly (Hamilton, CA)

Access the full session

Hot Line Session 1

Speakers: Professor P. Steg, Professor D. Bhatt, Professor C. Baigent, Professor S. Solomon, Doctor S. Connolly

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

Related content

ESC Premium Access

MASTER DAPT: dual antiplatelet therapy after coronary stenting in high bleeding risk patients

28 August 2021

ESC Premium Access

Cardiovascular benefit of lowering LDL-C below 1 mmol/L (40 mg/dl)

28 August 2021

Open Access

New recommendations for the treatment of HFrEF.

27 August 2021

ESC 365 is supported by